Two recent trials have shown benefit for low dose colchicine in reducing the risk of cardiovascular events in patients with a recent myocardial infarction as well as in patients with chronic cardiovascular disease.

For details, see the abstracts of the studies published in the NEJM: ‘Efficacy and safety of low-dose colchicine after Myocardial Infarction’ and ‘Colchicine in patients which Chronic Coronary Disease’.